EW

#313
Edwards Lifesciences Corporation Common Stock
86.1 5 USD
-1.06%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
85.84
86.72
Year Range
72.30
88.28
Daily Change
-1.06%
Monthly Change
+5.87%
6 month change
-0.49%
Year Change
+11.26%
Previous Close
87.0 7
Open
85.9 7
Low
85.8 4
High
86.7 2
Volume
716
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 49.61 B
  • Employee 16 K
  • Founded N/A
  • CEO -
  • Website www.edwards.com
  • Headquarter Delaware, United States
  • FIGI BBG000BRXP69
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
46.58
Price to sales ratio
8.26

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

News